Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I
- PMID: 24770496
- PMCID: PMC4008050
- DOI: 10.1590/abd1806-4841.20142334
Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I
Abstract
Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus. The clinical manifestations are variable and depend on the interaction of several factors including the site of infection and the host's immunity. This article revises the current knowledge about this disease's physiopathology and immunology as well as detailing the possible clinical presentations.
Conflict of interest statement
Conflict of Interest: None.
Figures
References
-
- Barbagallo J, Tager P, Ingleton R, Hirsch RJ, Weinberg JM. Cutaneous tuberculosis, diagnosis and treatment. Am J Clin Dermatol. 2002;3:319–328. - PubMed
-
- Almaguer-Chávez J, Ocampo-Candiani J, Rendón A. Current panorama in the diagnosis of cutaneous tuberculosis. Actas Dermosifiliogr. 2009;100:562–570. - PubMed
-
- Who.int . World Health Organization. Tuberculosis. [cited 2012 Oct 7]. [homepage na internet] Available from: www.who.int/tb/data.
-
- Saude.gov.br . Situação epidemiológica 2011. Brazilian Ministry of Health website. Epidemiological situation in 2011. [acesso 7 Out 2012]. [página da internet] Disponível em: http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1527.
-
- Sehgal VN, Bhattacharya SN, Jain S, Logani K. Cutaneous tuberculosis: the evolving scenario. Int J Dermatol. 1994;33:97–104. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources